Companies / Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc.
MRTXCIK 1576263
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | Boxer Capital, LLC 10% owner | Sell Open-market sale | Common Stock | $65.76M | -363K -15.36% | 2,000,000 | high |
| Aug 11, 2023 | Boxer Capital, LLC 10% owner | Buy Open-market buy | Common Stock | $33.40M | +1.2M +60.07% | 3,201,440 | high |
| Aug 11, 2023 | Boxer Capital, LLC 10% owner | Buy Open-market buy | Common Stock | $33.40M | +1.2M +60.07% | 3,201,440 | high |
| Jan 29, 2015 | Boxer Capital, LLC 10% owner | Buy Open-market buy | Common Stock | $10.00M | +500K | 500,000 | high |
| Jan 29, 2015 | Baker Bros. Advisors LP 10% owner | Buy Open-market buy | Common Stock | $7.82M | +391K +17.66% | 2,604,832 | high |
| Nov 28, 2022 | Baum Charles M CEO | Sell Open-market sale | Common Stock | $6.93M | -69K -35.13% | 127,899 | medium |
| Mar 5, 2021 | Boxer Capital, LLC 10% owner | Sell Open-market sale | Common Stock | $6.70M | -37K -13.84% | 230,333 | medium |
| Jun 18, 2021 | Baum Charles M CEO | Sell Open-market sale | Common Stock | $3.46M | -21K -15.47% | 113,737 | medium |